We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


UK Bionic Eye trial starts for dry AMD patients

The first study that aims to establish whether blind patients with loss of central vision due todry age-related macular degeneration (AMD) can benefit from an electronic artificial retina - the ArgusĀ® II retinal prosthesis system - has begun recruiting patients in the UK after receiving full trial approval. Previously, this, and the other retinal implants currently available, have been indicated only for use only in patients with the rare disease retinitis pigmentosa (RP). This is the first time that a retinal implant will beused to treat patients with AMD.

Prof Stanga outside MREH

The trial, which will take place at Manchester Royal Eye Hospital, led by Professor Paulo Stanga, was publicised yesterday on BBC North West Tonight and in the Manchester Evening News.

For the coverage, please go to:



Interested patients can call Danielle Ridyard, research assistant to Professor Stanga on 0161 701 7691 or email Danielle.ridyard@cmft.chs.uk.